JP2024519999A5 - - Google Patents

Info

Publication number
JP2024519999A5
JP2024519999A5 JP2023572714A JP2023572714A JP2024519999A5 JP 2024519999 A5 JP2024519999 A5 JP 2024519999A5 JP 2023572714 A JP2023572714 A JP 2023572714A JP 2023572714 A JP2023572714 A JP 2023572714A JP 2024519999 A5 JP2024519999 A5 JP 2024519999A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
liquid pharmaceutical
composition according
emulsion
forming excipients
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023572714A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024519999A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/030819 external-priority patent/WO2022251288A1/en
Publication of JP2024519999A publication Critical patent/JP2024519999A/ja
Publication of JP2024519999A5 publication Critical patent/JP2024519999A5/ja
Pending legal-status Critical Current

Links

JP2023572714A 2021-05-25 2022-05-25 高い薬物充填量の中鎖脂肪酸トリグリセリドを有する安定な液体医薬組成物およびそれに関連する方法 Pending JP2024519999A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163192826P 2021-05-25 2021-05-25
US63/192,826 2021-05-25
PCT/US2022/030819 WO2022251288A1 (en) 2021-05-25 2022-05-25 Stable liquid pharmaceutical compositions having high drug loadings of medium chain triglycerides and methods related thereto

Publications (2)

Publication Number Publication Date
JP2024519999A JP2024519999A (ja) 2024-05-21
JP2024519999A5 true JP2024519999A5 (cg-RX-API-DMAC7.html) 2025-06-02

Family

ID=82115983

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023572714A Pending JP2024519999A (ja) 2021-05-25 2022-05-25 高い薬物充填量の中鎖脂肪酸トリグリセリドを有する安定な液体医薬組成物およびそれに関連する方法

Country Status (10)

Country Link
US (1) US20240238199A1 (cg-RX-API-DMAC7.html)
EP (1) EP4346758A1 (cg-RX-API-DMAC7.html)
JP (1) JP2024519999A (cg-RX-API-DMAC7.html)
KR (1) KR20240012539A (cg-RX-API-DMAC7.html)
CN (1) CN117460495A (cg-RX-API-DMAC7.html)
AU (1) AU2022283278A1 (cg-RX-API-DMAC7.html)
CA (1) CA3220907A1 (cg-RX-API-DMAC7.html)
IL (1) IL308512A (cg-RX-API-DMAC7.html)
WO (1) WO2022251288A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA202311798B (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2024384650A1 (en) * 2023-11-26 2026-07-09 Cerecin Australia Pty Limited Formulations of lipid nano emulsions with controlled pharmacokinetic profiles and methods of making and using the same

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08505367A (ja) * 1992-10-16 1996-06-11 スミスクライン・ビーチャム・コーポレイション 医薬用エマルジョン組成物
ES2553132T3 (es) * 2008-04-22 2015-12-04 Azelis Deutschland Kosmetik Gmbh Utilización de ésteres de ácido cítrico como emulsionantes W/O
BR112016018673B1 (pt) * 2014-02-14 2023-10-17 Jingjun Huang Composição em nanoemulsão de óleo em água estável opticamente clara, método de produção da mesma, e, formulação de carreador
EA201992178A1 (ru) * 2017-03-15 2020-05-22 Сересин Инк. Фармацевтические композиции с высоким содержанием лекарственного средства из среднецепочечных триглицеридов и способы, связанные c ними
EP3934630A4 (en) * 2019-03-04 2022-11-23 Cerecin Inc. MEDIUM CHAIN TRIGLYCERIDE FORMULATIONS WITH IMPROVED BIOAVAILABILITY AND RELATED METHODS
US11857931B2 (en) * 2020-01-07 2024-01-02 WAKAMONO joint stock company Process for production of nano-microemulsion system of plant oil triglycerides

Similar Documents

Publication Publication Date Title
KR101904850B1 (ko) 마이봄선을 표적화하는 영양 보충물
DE2905979C2 (de) Verwendung von acetylierten, destillierten Monoglyceriden zur Behandlung von Fettstoffwechselstörungen beim Menschen
DE69818704T2 (de) Verfahren zur verbesserung der absorption und des transport von lipidlöslichen verbindungen mittels strukturierter glyceriden
DE69910183T2 (de) Darmlösliche sprudelnde zusammensetzungen
JP2019214598A5 (cg-RX-API-DMAC7.html)
DE60011771T2 (de) Formulierung enthaltend testosteonundecanoat und rizinusöl
JP2020517727A (ja) 安定なカンナビノイド製剤
JPH07502491A (ja) 皮膚疾患の治療に対して静脈的に投与される薬剤を調整するためのエマルジョンの使用
JPH06128154A (ja) 食品組成物
JP2023153863A (ja) 15-hepeを含む組成物及びその使用方法
WO2017204986A1 (en) Stable cannabinoid formulations
CN106256345A (zh) 维生素c传递系统及其脂质体组合物
WO2010057804A1 (de) Fettemulsion zur künstlichen ernährung von schwerkranken intensivpatienten
DE3785849T2 (de) Jod enthaltende emulsion.
WO2001068056A1 (de) Glucocorticoide in einer modified release-formulierung
EP1799204A1 (de) Omega-3-fettsäuren und omega-6-fettsäuren enthaltende zusammensetzung
JP3132085B2 (ja) 脂肪乳剤
JP4493018B2 (ja) 平滑筋蠕動抑制剤
JP2025525186A (ja) シクロスポリン乳剤およびその製造方法
DE112022003774T5 (de) Neue omega-3-trägerpräparate für die inhalation von medikamenten zur behandlung von lungenentzündungen
JPH10330250A (ja) メナテトレノン油性製剤
RS52735B (sr) Primena kombinacije koja sadrži l-karnitin ili alkanoil l-karnitin, benzokvinon rastvorljiv u mastima i omega-3-polinezasićenu masnu kiselinu za pripremu dodataka ishrani ili leka za lečenje oboljenja rožnjače
DE2654743A1 (de) Therapeutikum zur externen behandlung von schuppenflechte (psoriasis), flechten und ekzemen
RU2007145055A (ru) Стабильные составы наночастиц
JP3816545B2 (ja) 人工透析患者の皮膚そう痒症治療組成物及び副甲状腺機能亢進症治療組成物